BTIG Reiterates Buy on Verastem, Maintains $18 Price Target

BTIG analyst Jeet Mukherjee has reiterated a Buy rating on Verastem (NASDAQ: VSTM) and has maintained a price target of $18 for the stock. This endorsement suggests confidence in the company's future performance.